Lv21
108 积分 2024-09-04 加入
Targeting cuproplasia and cuproptosis in cancer
2小时前
已完结
New guidelines and definitions for type I photodynamic therapy
1个月前
已完结
Clinical and translational advances in ovarian cancer therapy
3个月前
已完结
A ROS-mediated resistance pathway to anticancer drugs
5个月前
已完结
CircRREB1 Mediates Metabolic Reprogramming and Stemness Maintenance to Facilitate Pancreatic Ductal Adenocarcinoma Progression
10个月前
已完结
To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy
1年前
已完结
皖公网安备34019202002308
